Mergers & Acquisitions Mergers & Acquisitions

Illumina gets formal EU charges calling for unwinding of Grail deal

American life sciences company Illumina has been served with an EU Statement of Objections outlining measures to unwind its acquisition of cancer-testing specialist Grail.

The European Commission said today that it has sent the companies a formal charge sheet informing them of the “restorative measures” it intends to take to restor

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News